These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7945561)
1. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Keidar S; Kaplan M; Shapira C; Brook JG; Aviram M Atherosclerosis; 1994 May; 107(1):71-84. PubMed ID: 7945561 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Keidar S; Kaplan M; Hoffman A; Aviram M Atherosclerosis; 1995 Jun; 115(2):201-15. PubMed ID: 7661879 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin, LDL peroxidation and atherosclerosis. Keidar S Life Sci; 1998; 63(1):1-11. PubMed ID: 9667759 [TBL] [Abstract][Full Text] [Related]
4. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Fuhrman B; Judith O; Keidar S; Ben-Yaish L; Kaplan M; Aviram M Free Radic Biol Med; 1997; 23(1):34-46. PubMed ID: 9165295 [TBL] [Abstract][Full Text] [Related]
5. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Aviram M; Eias K Ann Nutr Metab; 1993; 37(2):75-84. PubMed ID: 8517637 [TBL] [Abstract][Full Text] [Related]
6. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Fuhrman B; Oiknine J; Aviram M Atherosclerosis; 1994 Nov; 111(1):65-78. PubMed ID: 7840815 [TBL] [Abstract][Full Text] [Related]
7. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Keidar S; Kaplan M; Aviram M Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):97-105. PubMed ID: 8548433 [TBL] [Abstract][Full Text] [Related]
9. Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study. Rachmani R; Lidar M; Brosh D; Levi Z; Ravid M Diabetes Res Clin Pract; 2000 May; 48(2):139-45. PubMed ID: 10802151 [TBL] [Abstract][Full Text] [Related]
10. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. Steinbrecher UP; Lougheed M; Kwan WC; Dirks M J Biol Chem; 1989 Sep; 264(26):15216-23. PubMed ID: 2768257 [TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122 [TBL] [Abstract][Full Text] [Related]
12. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320 [TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Hoffman R; Brook GJ; Aviram M Atherosclerosis; 1992 Mar; 93(1-2):105-13. PubMed ID: 1596293 [TBL] [Abstract][Full Text] [Related]
14. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290 [TBL] [Abstract][Full Text] [Related]
15. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Hussein O; Rosenblat M; Refael G; Aviram M Transplantation; 1997 Mar; 63(5):679-85. PubMed ID: 9075838 [TBL] [Abstract][Full Text] [Related]
16. Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation. Ziedén B; Wuttge DM; Karlberg BE; Olsson AG Br J Clin Pharmacol; 1995 Feb; 39(2):201-3. PubMed ID: 7742164 [TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Hussein O; Schlezinger S; Rosenblat M; Keidar S; Aviram M Atherosclerosis; 1997 Jan; 128(1):11-8. PubMed ID: 9051193 [TBL] [Abstract][Full Text] [Related]
18. Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein. Levy Y; Kaplan M; Ben-Amotz A; Aviram M Isr J Med Sci; 1996 Jun; 32(6):473-8. PubMed ID: 8682654 [TBL] [Abstract][Full Text] [Related]
19. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia. Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M Int J Mol Med; 2000 Nov; 6(5):591-4. PubMed ID: 11029530 [TBL] [Abstract][Full Text] [Related]
20. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro. Menéndez R; Más R; Amor AM; González RM; Fernández JC; Rodeiro I; Zayas M; Jiménez S Br J Clin Pharmacol; 2000 Sep; 50(3):255-62. PubMed ID: 10971310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]